Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 25, 2016ChemMedChemOpen Access

Immunoproteasome β5i‐Selective Dipeptidomimetic Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

PSPradeep K. SinghRaNA Therapeutics (United States)HFHao FanAgency for Science, Technology and ResearchXJXiuju JiangCornell University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Singh et al. (2016) studied this question.

synapsesocial.com/papers/6a7097073ce530166bc2de1dhttps://doi.org/10.1002/cmdc.201600384
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nonpeptidic Selective Inhibitors of the Chymotrypsin‐Like (β5 i) Subunit of the Immunoproteasome2016 · 44 citations
  2. 2Inhibitors for the Immuno‐ and Constitutive Proteasome: Current and Future Trends in Drug Development2012 · 177 citations
  3. 3Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis2014 · 164 citations
  4. 4Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit2010 · 146 citations